Rosiglitazone inhibits vascular KATP channels and coronary vasodilation produced by isoprenaline. - Wikidata - wikimedia - TriplyDB

Rosiglitazone inhibits vascular KATP channels and coronary vasodilation produced by isoprenaline.

Rosiglitazone inhibits vascular KATP channels and coronary vasodilation produced by isoprenaline.

http://www.wikidata.org/entity/Q39524834

about

Pioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer's disease with combined amyloid-β and cerebrovascular pathology K(ATP) channel action in vascular tone regulation: from genetics to diseases.Differential sensitivities of the vascular K(ATP) channel to various PPAR activators Metabolic hyperemia requires ATP-sensitive K+ channels and H2O2 but not adenosine in isolated mouse hearts.Rosiglitazone selectively inhibits K(ATP) channels by acting on the K(IR) 6 subunit Prolonged exposure to methylglyoxal causes disruption of vascular KATP channel by mRNA instability Relaxation of human pulmonary arteries by PPARγ agonists.Optogenetic approach for functional assays of the cardiovascular system by light activation of the vascular smooth muscle.Acute exposure of methylglyoxal leads to activation of KATP channels expressed in HEK293 cells.Selective block of K(ATP) channels: why the anti-diabetic sulphonylureas and rosiglitazone have more in common than we thought.Impairment of the Vascular KATP Channel Imposes Fatal Susceptibility to Experimental Diabetes Due to Multi-Organ Injuries.

P2860

Q28594423-8A48461B-0640-4117-B482-BD3E8F383E41 Q34044875-9AAC5BD5-025A-45A0-B8E2-1110E70C2730 Q34044879-3F222163-296F-4B06-A039-766901AAE3DD Q34295446-FE49F11D-FB83-4D19-83C0-EEF4621510B5 Q36252833-F125A4C2-1ACF-4457-9F05-BA7ED5FB02CC Q36382451-A7D58587-904D-4AA1-8E25-06D219336485 Q36755896-082260B8-565B-4C01-951D-EE46226FCCFE Q36862011-32819B3F-27AE-421B-BDF1-88B2B753E17B Q41502455-02F55D34-339B-4516-B6FA-A3498626A2B5 Q42055085-296F6A0F-8451-47D3-9B32-434C66503341 Q46751044-7F7669A1-098E-42E1-8A17-5DBB47CAF425

P2860

Rosiglitazone inhibits vascular KATP channels and coronary vasodilation produced by isoprenaline.

http://www.wikidata.org/entity/Q39524834

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Rosiglitazone inhibits vascula ...... tion produced by isoprenaline.

@en

Rosiglitazone inhibits vascula ...... tion produced by isoprenaline.

@nl

type

label

Rosiglitazone inhibits vascula ...... tion produced by isoprenaline.

@en

Rosiglitazone inhibits vascula ...... tion produced by isoprenaline.

@nl

prefLabel

Rosiglitazone inhibits vascula ...... tion produced by isoprenaline.

@en

Rosiglitazone inhibits vascula ...... tion produced by isoprenaline.

@nl

P1433

Q39524834-565F8064-73E3-4158-8B0C-67BEFC938929

P1476

Q39524834-8E0CA7D6-F1CB-4218-B8C3-8E588BB682B3

P2093

Q39524834-17C2F4BC-C1D8-4877-9EE6-44B7272B0A15

Q39524834-7DBD1B30-E679-46A2-BDA3-BF2D2119B9DC

Q39524834-84574710-BDBB-4044-BB78-827A4B54F60C

Q39524834-E55ECBDD-BB61-41EB-A6FD-C93A083ECE50

P2860

Q39524834-006BCFCB-1509-4E87-91D6-9B7AD1A47E74

Q39524834-009D7A00-3595-4F97-9D80-08DE0C19BFED

Q39524834-0DA6B92B-FF12-49F7-B1B6-82F547EC6395

Q39524834-13C23784-5577-40EE-80FC-AA853281EA49

Q39524834-217A0447-1081-4E81-A6E0-024E089B1608

Q39524834-3BE7B140-EFDE-44A7-AABF-BE893E2C4421

Q39524834-406E78EF-758A-485B-BEDB-6FA1D962FA02

Q39524834-42773B1F-8376-48DD-940B-91BEACE03E2A

Q39524834-46096018-92C2-41A9-B785-9BDEEC48448C

Q39524834-4744E0F4-F9B5-4FFC-BA63-1A623FBEBBD2

P304

Q39524834-B3ECE85A-96CF-4961-B308-D4C91741AF6A

P31

Q39524834-75737BDD-8FBC-41F1-B6E0-02A6204BB79A

P356

Q39524834-744772F3-DBBA-4354-9D8E-6EDD5584BC8F

P407

Q39524834-74E8F6C1-803C-4ABB-87E4-4BAD2F366BF3

P433

Q39524834-30D23F59-989B-4D77-AA22-DA020AD7C135

P478

Q39524834-B5BB4F5F-D108-4B8E-B22E-E688CBC508BB

P50

Q39524834-CA7AC315-0FEB-4DA1-9579-A92A1449E5A6

Q39524834-DCD2C2CF-84CA-4D9B-B017-A87360D666DA

P577

Q39524834-EFBBE931-06D1-4A00-B2B0-F3B4D6906B0A

P5875

Q39524834-5C972C1B-70A4-4AF6-A950-787593715290

P698

Q39524834-8349AC88-A818-4C5A-BCB8-B8DEBEB38696

P932

Q39524834-C4F6EE07-E4F9-47B3-8BE1-5B4E9BD92D64

P356

J.1476-5381.2011.01539.X

P1433

British Journal of Pharmacology

P1476

Rosiglitazone inhibits vascula ...... ation produced by isoprenaline

@en

P2093

Chun Jiang

http://www.w3.org/2001/XMLSchema#string

Lei Yu

http://www.w3.org/2001/XMLSchema#string

Ningren Cui

http://www.w3.org/2001/XMLSchema#string

Xin Jin

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels

Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1

KATP channels as molecular sensors of cellular metabolism

Arginine vasopressin inhibits Kir6.1/SUR2B channel and constricts the mesenteric artery via V1a receptor and protein kinase C

Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model

Effects of intensive glucose lowering in type 2 diabetes

Glucose control and vascular complications in veterans with type 2 diabetes

Molecular basis and structural insight of vascular K(ATP) channel gating by S-glutathionylation.

Lipopolysaccharides up-regulate Kir6.1/SUR2B channel expression and enhance vascular KATP channel activity via NF-kappaB-dependent signaling

P304

2064-2072

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1476-5381.2011.01539.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

164

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51217948

http://www.w3.org/2001/XMLSchema#string

P698

21671900

http://www.w3.org/2001/XMLSchema#string

P932

3246668

http://www.w3.org/2001/XMLSchema#string